Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. OMDA
OMDA logo

OMDA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Omada Health Inc (OMDA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
17.640
1 Day change
2.26%
52 Week Range
28.400
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Omada Health Inc (OMDA) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows positive analyst sentiment with multiple price target upgrades, strong membership growth, and improving gross margins. While technical indicators are neutral, the stock's trend and options data suggest a favorable outlook. Despite the lack of recent news or congress trading data, the positive catalysts outweigh the negatives, making it a suitable long-term investment.

Technical Analysis

The MACD histogram is -0.153, below 0, and negatively contracting, indicating a lack of bullish momentum. RSI is neutral at 55.209, and moving averages are converging, showing no clear trend. Key support and resistance levels are Pivot: 17.636, R1: 18.378, S1: 16.893, R2: 18.837, S2: 16.434. The stock has a 70% chance to increase by 5.47% in the next month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios in both open interest and volume indicate a strong bullish sentiment among options traders.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
1
Buy
14

Positive Catalysts

  • Multiple analyst upgrades with increased price targets (ranging from $18 to $26).

  • Strong membership growth of 51% and crossing one million enrolled members.

  • Improved gross margins and enrollment yield rates.

  • Positive sentiment from options data.

Neutral/Negative Catalysts

  • Lack of recent news or event-driven catalysts.

  • Neutral trading sentiment from hedge funds and insiders.

Financial Performance

No financial data available for the latest quarter due to an error in data retrieval.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are overwhelmingly positive, with multiple Buy and Outperform ratings. Recent price target increases reflect confidence in the company's growth potential and operational improvements.

Wall Street analysts forecast OMDA stock price to rise
9 Analyst Rating
Wall Street analysts forecast OMDA stock price to rise
8 Buy
1 Hold
0 Sell
Strong Buy
Current: 17.250
sliders
Low
17
Averages
27
High
32
Current: 17.250
sliders
Low
17
Averages
27
High
32
Goldman Sachs
David Roman
Buy
maintain
$23 -> $26
AI Analysis
2026-05-08
Reason
Goldman Sachs
David Roman
Price Target
$23 -> $26
AI Analysis
2026-05-08
maintain
Buy
Reason
Goldman Sachs analyst David Roman raised the firm's price target on Omada Health to $26 from $23 and keeps a Buy rating on the shares.
Canaccord
Buy
maintain
$22 -> $24
2026-05-08
Reason
Canaccord
Price Target
$22 -> $24
2026-05-08
maintain
Buy
Reason
Canaccord raised the firm's price target on Omada Health to $24 from $22 and keeps a Buy rating on the shares. The firm said Omada posted a "milestone" quarter with enrolled members rising 51% and crossing one million while topping firm estimate by 4%.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for OMDA
Unlock Now

People Also Watch